Using technology in combination with behavioral science licensed from Duke University, Raleigh startup Improved Patient Outcomes says it has developed solutions to combat non-adherence to medication by patients.

Take your meds, improve your health – that’s part of the message the startup will present at the CED Tech Venture conference.

For a quick overview, see a newly published overview video at YouTube: https://www.youtube.com/watch?v=YBljY_XzKQU

Here’s a Q&A about Improved Patient Outcomes, presented as part of a partnership between the CED and WRAL TechWire.

  • What is the focus of your business?

Improving Patient Outcomes and lowering healthcare costs by marrying behavioral science and technology.

  • What is the top pain point/business application you are seeking to address?

We increase patient adherence to medication by 25% or more. Medication non-adherence is a $ 300 billion problem annually.

  • What makes it unique?

We use mobile apps, web, email, sms, phone, pharmacist and other forms of patient engagement combined with 20 years of behavioral research to change patient behavior.

  • Why should investors be interested in your firm?

Our behavioral science is part of an exclusive license from Duke University School of Medicine developed with over $80mm in funding and proven to work in over 70 programs with 20,000+ patients. Relative risk is low and management is well-versed in lifecycle of startup to growth stage and beyond.

Business facts:

  • Website – http://www.IPOHealthMatters.com
  • Email address for inquiries – clients@IPOHealthMatters.com
  • Physical address – Raleigh, NC
  • CEO – Gregory A. Muffler